Electronic cigarettes and nicotine clinical pharmacology

Tobacco Control

Volumn 23, Issue SUPPL. 2, 2014, Pages

  Schroeder, Megan J ^a   Hoffman, Allison C ^a  

^a CENTER FOR TOBACCO PRODUCTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE; NICOTINE;

BLOOD; ELECTRONIC CIGARETTE; HUMAN; TOBACCO DEPENDENCE;

COTININE; ELECTRONIC CIGARETTES; HUMANS; NICOTINE; TOBACCO USE DISORDER;

EID: 84899641535     PISSN: 09644563     EISSN: 14683318     Source Type: Journal    
DOI: 10.1136/tobaccocontrol-2013-051469     Document Type: Article

References (32)

1. U.S. Department of Health and Human Services. The health consequences of smoking: nicotine addiction: a report of the surgeon general. 1988. http://profiles. nlm.nih.gov/ps/access/NNBBZD.pdf (accessed 3 Dec 2012).
2. Goniewicz ML, Kuma T, Gawron M, et al. Nicotine levels in electronic cigarettes. Nicotine Tob Res 2013;15:158-66.
3. Trehy ML, Ye W, Hadwiger ME, et al. Analysis of electronic cigarette cartridges, refill solutions, and smoke for nicotine and nicotine related impurities. J Liquid Chromatogr Relat Technol 2011;34:1442-58.
4. Seigel MB, Tanwar KL, Wood KS. Electronic cigarettes as a smoking-cessation tool: results from an online survey. Am J Prev Med 2011;40:472-5.
5. Etter JP, Bullen C. Electronic cigarettes: users profile, utiliziation, satisfaction, and perceived efficacy. Addiction 2011;106:2017-28.
6. Henningfield JE, Keenan RM. Nicotine delivery kinetics and abuse liability. J Consult Clin Psychol 1993;61:743-50.
7. Berridge MS, Apana SM, Nagano KK, et al. Smoking produces rapid rise of [11C] nicotine in human brain. Psychopharmacology (Berl) 2010;209:383-94.
8. Westenberger BJ. Evaluation of e-cigarettes FDA. 2009. http://www.fda.gov/ downloads/drugs/Scienceresearch/UCM173250.pdf (accessed 12 Sept 2013).
9. Cobb NK, Byron MJ. Novel nicotine delivery systems and public health: the rise of the "e-cigarette". Am J of Public Health 2010;100:2340-2.
10. Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control 2014;23:133-9.
11. McAuley TR, Hopke PK, Zhao J, et al. Comparison of the effects of e-cigarette vapor and cigarette smoke on indoor air quality. Inhal Toxicol 2013;24:850-7.
12. Pellegrino RM, Tinghino B, Mangiaracina G, et al. Electronic cigarettes: an evaluation of exposure to chemicals and fine particulate matter (PM). Ann Ig 2012;24:279-88.
13. Farsalinos KE, Romagna G, Tsiapras D, et al. Evaluation of electronic cigarette use (vaping) topography and estimation of liquid consumption: implications for research protocol standards definition and for public health authorities' regulation. Int J Environ Res Public Health 2013;10:2500-14.
14. Benowitz NL, Jacob P III. Daily intake of nicotine during cigarette smoking. Clin Pharmacol Ther 1984;35:499-504.
15. Hoffmann D, Djordjevic MV, Hoffmann I. The changing cigarette. Prev Med 1997;26:427-34.
16. Hukkanen J, Jacob P III, Benowitz NL. Metabolism and disposition kinetics of nicotine. Pharmacol Rev 2005;57:79-115.
17. Bullen C, McRobbie H, Thornley S, et al. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: Randomised cross-over trial. Tob Control 2010;19:98-103.
18. Lunell E, Curvall M. Nicotine delivery and subjective effects of Swedish portion snus compared with 4 mg nicotine polacrilex chewing gum. Nicotine Tob Res 2011;13:573-8.
19. Eissenberg T. Electronic nicotine delivery devices: Ineffective nicotine delivery and craving suppression after acute administration. Tob Control 2010;19:87-8.
20. Vansickel AR, Cobb CO, Weaver MF, et al. A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol Biomarkers Prev 2010;19:1945-53.
21. Vansickel AR, Weaver MF, Eissenberg T. Clinical laboratory assessment of the abuse liability of an electronic cigarette. Addiction 2012;107:1493-500.
22. Flouris AD, Chorti MS, Poulianiti KP, et al. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol 2013;25:91-101.
23. Etter JF, Bullen C. Saliva cotinine levels in users of electronic cigarettes. Eur Respir J 2011;38:1219-20.
24. Wall MA, Johnson J, Jacob P III, et al. Cotinine in the serum, saliva, and urine of nonsmokers, passive smokers, and active smokers. Am J Public Health 1988;78:699-701.
25. Vansickel AR, Eissenberg T. Electronic cigarettes: Effective nicotine delivery after acute administration. Nicotine Tob Res 2013;15:267-70.
26. Dawkins L, Corcoran O. Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacology (Berl) 2014;231:401-7.
27. Benowitz NL, Jacob P III, Herrera B. Nicotine intake and dose repsponse when smoking reduced-nicotine content cigarettes. Clin Pharmacol Ther 2006;80:703-14.
28. Caponnetto P, Campagna D, Cibella F, et al. Efficiency and safety of an electronic cigarette (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS ONE 2013;8:e66317.
29. Benowitz NL. Cigarette smoking and cardiovascular disease: Pathophysiology and implications for treatment. Prog Cardiovasc Dis 2003;46:91-111.
30. Fagerström K, Eissenberg T. Dependence on tobacco and nicotine products: a case for product-specific assessment. Nicotine Tob Res 2012;14:1382-90.
31. Hoffman AC, Evans SE. Abuse potential of non-nicotine tobacco smoke components: acetaldehyde, nornicotine, cotinine, and anabasine. Nicotine Tob Res 2012;15:622-32.
32. Etter JF, Zäther E, Svensson S. Analysis of refill liquids for electronic cigarettes. Addiction 2013;108:1671-9.